Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector, particularly in the medical devices industry, is currently presenting a compelling opportunity..
Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector specializing in medical devices, has been capturing investor attention with its innovative approach to treating..
Soleno Therapeutics, Inc. (NASDAQ: SLNO) stands at the forefront of the biotechnology sector, focusing on the development of novel therapeutics for rare diseases. With a market..
Atrium Therapeutics, Inc. (NASDAQ: RNA), a promising player in the biotechnology sector, is capturing investor attention with a striking 86.15% potential upside, according to analyst ratings...
Molina Healthcare Inc (MOH), a stalwart in the healthcare plans industry, is a significant player in the U.S. healthcare market, providing managed healthcare services to low-income..
As an integral player in the healthcare sector, Qiagen N.V. (NYSE: QGEN) operates in the diagnostics and research industry, providing transformative solutions that convert biological samples..
HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable entity within the healthcare sector, specifically in the medical care facilities industry. With its headquarters nestled in..
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector with its focus on developing innovative therapies for central nervous system (CNS) disorders. With..
Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector’s Diagnostics & Research industry, is capturing investor attention with a potential upside of 25.52%. This..
Revolution Medicines, Inc. (NASDAQ: RVMD) is a formidable player in the biotechnology sector, with a focus on precision oncology. Specializing in developing targeted therapies for RAS-addicted..
HealthEquity, Inc. (NASDAQ: HQY), a prominent player in the healthcare information services industry, is grabbing the attention of savvy investors with its significant growth potential and..
Alkermes plc (NASDAQ: ALKS) is capturing investor attention with its potential upside of 33.40%, as indicated by its average target price of $44.53. This Ireland-based biopharmaceutical..
Investors with an eye on the healthcare sector may find AbbVie Inc. (NYSE: ABBV) an enticing opportunity. With a market capitalization of $365.43 billion, this U.S.-based..
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector with its promising advancements in treating rare neuroendocrine diseases. With a current market capitalization..
For investors with a keen interest in the biotechnology sector, Corcept Therapeutics Incorporated (NASDAQ: CORT) presents an intriguing prospect. With a market capitalization of $5.52 billion,..
ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the healthcare sector, operates within the biotechnology industry, specializing in the development and commercialization of plasma-derived biologics...
AstraZeneca PLC (AZN), a leading player in the biopharmaceutical sector, continues to capture investor attention with its robust market presence and a significant potential upside. This..
Cardinal Health, Inc. (NYSE: CAH) is a heavyweight in the healthcare sector, specializing in medical distribution—a critical industry that ensures the smooth delivery of healthcare products..
Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, presents an intriguing opportunity for..
